Ultra-low-dose ketamine may slow opioid withdrawal
Drug overdose is the leading cause of injury-related death among young adults in the United States, with fentanyl causing more… Read More »Ultra-low-dose ketamine may slow opioid withdrawal
Drug overdose is the leading cause of injury-related death among young adults in the United States, with fentanyl causing more… Read More »Ultra-low-dose ketamine may slow opioid withdrawal
Adversity in early life can have lifelong consequences for people’s health, even if their circumstances improve dramatically later in life.… Read More »Difficulties in early life can affect health and longevity, even in marmots
A new study suggests that neighborhoods with fewer educational, health, environmental, and socioeconomic resources may increase the risk of preterm… Read More »Less opportunity in the neighborhood may increase the risk of premature birth
Scientists at Kyoto University’s Institute for Integrated Cellular Materials Science (WPI-iCeMS) have uncovered new details about how cells manage the… Read More »New proteins involved in cell membrane regulation
Now, a team of researchers at UBC Okanagan believe they have found a way to harness the advantages of both… Read More »A revolutionary advance in heart valve technology
Babies born to obese pregnant women are more likely to develop heart problems and diabetes as adults because of fetal… Read More »Babies born to women who consume a diet high in fat and sugar have a higher risk of cardiovascular disease and diabetes later in life.
A drug that delivers chemotherapy directly to tumors has shown impressive activity against some of the hardest-to-reach cancer cells: those… Read More »Antibody-drug conjugate effective against brain metastases in patients with HER2-positive breast cancer
A Cleveland Clinic study identified key factors that may affect long-term weight loss in obese patients prescribed injectable semaglutide or… Read More »Key factors affecting long-term weight loss in patients prescribed GLP-1 AR medications
Interim data from a Phase I dose-escalation trial of mRNA cancer immunotherapy (mRNA-4359) are promising in patients with advanced solid… Read More »Experimental mRNA cancer vaccine shows potential for patients with advanced cancer in phase 1 trial
A UC Davis Health study found that 22 percent of adults and 10 percent of children in an air quality… Read More »San Joaquin Valley residents breathe chemical pesticides, new study finds